Product NDC: | 55648-781 |
Proprietary Name: | Entacapone |
Non Proprietary Name: | Entacapone |
Active Ingredient(s): | 200 mg/1 & nbsp; Entacapone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55648-781 |
Labeler Name: | Wockhardt Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020796 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20120930 |
Package NDC: | 55648-781-02 |
Package Description: | 1 BOTTLE in 1 CARTON (55648-781-02) > 100 TABLET, FILM COATED in 1 BOTTLE |
NDC Code | 55648-781-02 |
Proprietary Name | Entacapone |
Package Description | 1 BOTTLE in 1 CARTON (55648-781-02) > 100 TABLET, FILM COATED in 1 BOTTLE |
Product NDC | 55648-781 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Entacapone |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20120930 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Wockhardt Limited |
Substance Name | ENTACAPONE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC] |